INT246393

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.49
First Reported 2008
Last Reported 2008
Negated 1
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.14
Pain Relevance 0.11

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (Ccnd2) nucleolus (Ccnd2) nucleus (Ccnd2)
cell cycle (Ccnd2) cell division (Ccnd2) cytoplasm (Ccnd2)
Ccnd2 (Mus musculus)
Pain Link Frequency Relevance Heat
Pain 2 83.80 Quite High
cytokine 1 53.00 Quite High
ketamine 3 5.00 Very Low Very Low Very Low
Inflammatory response 3 5.00 Very Low Very Low Very Low
tolerance 3 5.00 Very Low Very Low Very Low
Buprenorphine 1 5.00 Very Low Very Low Very Low
analgesia 1 5.00 Very Low Very Low Very Low
isoflurane 1 5.00 Very Low Very Low Very Low
Potency 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Yersinia Infection 13 98.96 Very High Very High Very High
Pressure And Volume Under Development 2 84.16 Quite High
Injury 7 83.36 Quite High
Bites And Stings 1 81.56 Quite High
Hyperglycemia 2 71.04 Quite High
Septic Shock 10 67.00 Quite High
Bacillus Anthracis Infection 13 59.20 Quite High
Gastroenteritis 12 58.48 Quite High
Sepsis 1 41.60 Quite Low
Animal Disease Models 1 40.08 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
However, we included F1-V in our study to increase the complexity of the vaccine combination and because this high-profile product is ultimately intended for human use.
Positive_regulation (increase) of V in
1) Confidence 0.49 Published 2008 Journal J Immune Based Ther Vaccines Section Body Doc Link PMC2543000 Disease Relevance 0.99 Pain Relevance 0.11
A similar trend was observed for Ccna2 but not for Ccnd2, both of which have been linked to ?
Neg (not) Positive_regulation (observed) of Ccnd2
2) Confidence 0.44 Published 2008 Journal Diabetes Section Body Doc Link PMC2570403 Disease Relevance 0.15 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox